Dr. Benjamin Kelmendi, MD
Claim this profileConnecticut Mental Health Center, Yale University
Studies Major Depression
Studies Major Depressive Disorder
2 reported clinical trials
1 drug studied
Affiliated Hospitals
Clinical Trials Benjamin Kelmendi, MD is currently running
Psilocybin
for Obsessive-Compulsive Disorder
This trial tests if taking psilocybin pills can help people with OCD by changing how their brain processes thoughts and emotions. The study compares different amounts of psilocybin to see if it reduces OCD symptoms more effectively. Psilocybin is a naturally occurring substance that has shown promise in treating mood and substance use disorders.
Recruiting1 award Phase 17 criteria
Psilocybin
for Depression
This trial is testing psilocybin, a substance from mushrooms, to see if it can help adults with depression who may not respond well to current treatments. Psilocybin works by affecting brain chemicals related to mood. Psilocybin has shown promise as a treatment for major depressive disorder and was designated as a breakthrough therapy by the FDA in 2019.
Recruiting1 award Phase 33 criteria
More about Benjamin Kelmendi, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Benjamin Kelmendi, MD has experience with
- Psilocybin
Breakdown of trials Benjamin Kelmendi, MD has run
Major Depression
Major Depressive Disorder
Obsessive-Compulsive Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Kelmendi, MD specialize in?
Benjamin Kelmendi, MD focuses on Major Depression and Major Depressive Disorder. In particular, much of their work with Major Depression has involved treating patients, or patients who are undergoing treatment.
Is Benjamin Kelmendi, MD currently recruiting for clinical trials?
Yes, Benjamin Kelmendi, MD is currently recruiting for 2 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Kelmendi, MD has studied deeply?
Yes, Benjamin Kelmendi, MD has studied treatments such as Psilocybin.
What is the best way to schedule an appointment with Benjamin Kelmendi, MD?
Apply for one of the trials that Benjamin Kelmendi, MD is conducting.
What is the office address of Benjamin Kelmendi, MD?
The office of Benjamin Kelmendi, MD is located at: Connecticut Mental Health Center, Yale University, New Haven, Connecticut 06519 United States. This is the address for their practice at the Connecticut Mental Health Center, Yale University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.